SUNDYS: A Multicenter, Randomized, Double-blind, Sham-controlled,

Status Recruiting

Clinical Trial Summary

Dystonia is a group of movement disorders characterized by twisting, repetitive movements, or abnormal postures caused by involuntary muscle contractions and is characterized by a young age of onset and a high disability rate. Early intervention can reduce disability incidence, improve the patient's quality of life, and reduce the burden on families and society. Multiple international guidelines on dystonia have found deep brain stimulation (DBS) to be a safe and effective treatment for refractory dystonia. The globus pallidal internus (GPi) is the mostly widely used target for dystonia. However, there are limitations on the GPi DBS treatment, including slow onset of beneficial effects, poor improvement of axis symptoms, and potential stimulation-related side effects. Previous studies have described the highly successful use of subthalamic nucleus deep brain stimulation (STN DBS) in patients with refractory dystonia, suggesting that STN DBS is an effective and persisting alternative to pallidal deep brain stimulation. However, all STN DBS treated cases have been analyzed in open-label uncontrolled cohort studies, leading to limited data with a high level of evidence on the STN DBS in dystonia. Further, the investigators hypothesized STN has potentially more effectiveness when compared with GPi, and may be more power-saving and quick-acting. In this study, the investigators will organize a prospective randomized, double-blind, parallel-group, multicenter study comparing active versus sham stimulation in isolated segmental or generalized dystonia to evaluate the effectiveness and safety of STN DBS by measuring the impact on motor status, mental status, quality of life, the rate of response of the patients (the number of patients with ≥30% improvement in the movement score on the Burke-Fahn-Marsden Dystonia Rating Scale) and the rate of adverse events during the trial.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT04650958
Study type	Interventional
Source	Ruijin Hospital
Contact	Kejia Hu, MD, PhD
Phone	18930113801
Email	dockejiahu@gmail.com
Status	Recruiting
Phase	N/A
Start date	January 1, 2021
Completion date	January 1, 2022

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01433757` - Ampicillin for DYT-1 Dystonia Motor Symptoms	Phase 1
Recruiting	`NCT00971854` - Alteration of Deep Brain Stimulation Parameters for Dystonia	N/A
Enrolling by invitation	`NCT00355927` - Sedation During Microelectrode Recordings Before Deep Brain Stimulation for Movement Disorders.	N/A
Completed	`NCT00169338` - Pallidal Stimulation in Patients With Post-anoxic and Idiopathic Dystonia	Phase 2
Completed	`NCT00004421` - Deep Brain Stimulation in Treating Patients With Dystonia	Phase 2/Phase 3
Terminated	`NCT03270189` - Effect of the Visual Information Change in Functional Dystonia	N/A
Recruiting	`NCT02583074` - Clinical Trial of STN-DBS for Primary Cranial-Cervical Dystonia	N/A
Recruiting	`NCT06117020` - Single and Multiple Ascending Dose Study of MTR-601 in Healthy Individuals	Phase 1
Completed	`NCT01432899` - Studying Childhood-Onset Hemidystonia
Completed	`NCT04948684` - Efficacy of Botulinum Toxin for the Treatment of Dystonia Associated With Parkinson's Disease and Atypical Parkinsonism
Completed	`NCT05106816` - The Effects of Vibrotactile Stimulation in Patients With Movement Disorders	N/A
Recruiting	`NCT05027997` - Exploratory Study of Dipraglurant (ADX48621) for the Treatment of Patients With Blepharospasm	Phase 2
Completed	`NCT00465790` - Research of Biomarkers in Parkinson Disease	Phase 0
Active, not recruiting	`NCT00142259` - Efficacy and Safety of DBS of the GPi in Patients With Primary Generalized and Segmental Dystonia	Phase 4
Recruiting	`NCT05663840` - Effects of Exercise on Dystonia Pathophysiology	N/A
Not yet recruiting	`NCT06038097` - Efficacy and Safety of Radiofrequency Pallidotomy in the Management of Dystonia	N/A
Recruiting	`NCT04286308` - Cortical-Basal Ganglia Speech Networks	N/A
Active, not recruiting	`NCT03582891` - The Motor Network in Parkinson's Disease and Dystonia: Mechanisms of Therapy	N/A
Completed	`NCT03318120` - Exercise Training in Dystonia	N/A
Completed	`NCT04568681` - Deep Brain Stimulation Effects in Dystonia

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

SUNDYS: A Multicenter, Randomized, Double-blind, Sham-controlled, Parallel-group Trial — SUNDYS

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms